Articles from Great Point Partners

Great Point Partners, (“Great Point”) a Greenwich-based private investment firm focused exclusively on the health care industry, announced today that it was again recognized on Inc.’s Founder-Friendly Investors list. This list honors the private equity, venture capital, and debt firms with track records of successfully partnering with the founder-led businesses they invest in, while maintaining their entrepreneurial spirit. This marks the third consecutive year that Inc. has recognized Great Point Partners track accomplishments in this area.

Great Point Partners (“GPP” or “the Firm”), a Greenwich-based private investment firm focused exclusively on the health care industry, announced today the acquisition of a majority stake in Eutecma (or “the Company”), a German-based developer of sustainable, modular, and reusable temperature controlled packaging solutions for pharmaceutical cold chain shipments.

Great Point Partners (“GPP”), a Greenwich-based investment firm focused exclusively on the health care industry, today announced the acquisition of Lyocontract GmbH (“Lyocontract”), a premium independent drug product contract development and manufacturing organization (“CDMO”) based in Ilsenburg, Germany.

Great Point Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, celebrated its 20th anniversary of partnering with growing health care companies and helping them achieve their full potential.

Great Point Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, today announced the growth recapitalization of Ludi, Inc. (“Ludi”), the leader in physician payment automation, based in Nashville, TN.

Great Point Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, announced today that it was included on Inc.’s Founder-Friendly Investors list, which honors the private equity, venture capital, and debt firms with track records of successfully partnering with entrepreneurs.

Great Point Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, today announced that it has exited its investment in Vālenz® Health (“Valenz”) to Kelso & Company (“Kelso”), a New York-based private equity firm, after growing revenue close to 30% per year during a six-year partnership.

Great Point Partners (“GPP”), a Greenwich-based private investment firm, has opened an office in London, expanding the firm’s ability to help growing health care companies reach transatlantic scale.

Cellipont Bioservices (Cellipont), a cell therapy contract development and manufacturing organization (CDMO), announced a strategic debt facility investment from OrbiMed, a healthcare investment firm. The investment will be used by Cellipont to fully finance the previously announced state-of-the-art commercial facility for cell therapies and gene-modified cell therapies in The Woodlands, Texas.